International Biotechnology (LON:IBT - Get Free Report) shares passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 690.81 ($8.69) and traded as high as GBX 733.88 ($9.24). International Biotechnology shares last traded at GBX 716 ($9.01), with a volume of 98,940 shares trading hands.
International Biotechnology Price Performance
The company has a market capitalization of £253.60 million, a P/E ratio of 6.74 and a beta of 0.21. The company's 50-day moving average price is GBX 701.64 and its two-hundred day moving average price is GBX 691.20.
International Biotechnology Increases Dividend
The firm also recently declared a dividend, which was paid on Friday, January 24th. Investors of record on Thursday, December 19th were given a dividend of GBX 15.56 ($0.20) per share. This represents a yield of 2.21%. This is a positive change from International Biotechnology's previous dividend of $14.50. The ex-dividend date was Thursday, December 19th. International Biotechnology's dividend payout ratio (DPR) is currently 27.67%.
Insider Buying and Selling
In other news, insider Katherine Cornish-Bowden acquired 1,500 shares of International Biotechnology stock in a transaction on Tuesday, December 17th. The shares were purchased at an average cost of GBX 713 ($8.97) per share, for a total transaction of £10,695 ($13,461.30). 4.18% of the stock is owned by insiders.
International Biotechnology Company Profile
(
Get Free Report)
The Company's investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.
The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.
Featured Stories
Before you consider International Biotechnology, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and International Biotechnology wasn't on the list.
While International Biotechnology currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
